Anti-adipogenic activities of Alnus incana and Populus balsamifera bark extracts, part I: Sites and mechanisms of action

Planta Medica

Volumn 76, Issue 13, 2010, Pages 1439-1446

  Martineau, Louis C ^a,c   Hervé, Jessica ^a,c   Muhamad, Asim ^b,c   Saleem, Ammar ^b,c   Harris, Cory S ^b,c   Arnason, John T ^b,c   Haddad, Pierre S ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

Author keywords

(Du roi) R.T. Clausen; 3T3L1 adipocyte; aboriginal traditional medicine; Alnus incana ssp. rugosa; Betulaceae; obesity; peroxisome proliferator activated receptor gamma; Populus balsamifera L.; Salicaceae

Indexed keywords

ALNUS INCANA EXTRACT; ANTIOBESITY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; POPULUS BALSAMIFERA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOGENESIS; ALNUS INCANA; ANIMAL CELL; ARTICLE; BARK; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL SHAPE; CELL STRAIN 3T3; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; EMBRYO; FIBROBLAST; HUMAN; HUMAN CELL; MEDICINAL PLANT; MOUSE; NONHUMAN; POPULUS BALSAMIFERA; PROADIPOCYTE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ALNUS; ANIMALS; ANTI-OBESITY AGENTS; CELL PROLIFERATION; FIBROBLASTS; MICE; OBESITY; PLANT BARK; PLANT EXTRACTS; POPULUS; PPAR GAMMA; TRIGLYCERIDES;

ALNUS INCANA; BETULACEAE; POPULUS BALSAMIFERA; SALICACEAE;

EID: 77956705076     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1240941     Document Type: Article

References (28)

1. James P T., Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004 11 3-8
2. Prentice A M. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006 35 93-99
3. Hainer V, Toplak H, Mitrakou A. Treatment modalities of obesity: what fits whom? Diab Care 2008 31 (Suppl.2) S269-S277
4. Chaput J P., Tremblay A. Current and novel approaches to the drug therapy of obesity. Eur J Clin Pharmacol 2006 62 793-803
5. Harp J B. New insights into inhibitors of adipogenesis. Curr Opin Lipidol 2004 15 303-307
6. Petersen K F., Shulman G I. Etiology of insulin resistance. Am J Med 2006 119 S10-S16
7. Wang P, Mariman E, Renes J, Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 2008 216 3-13
8. Feve B. Adipogenesis: cellular and molecular aspects. Best Pract Res Clin Endocrinol Metab 2005 19 483-499
9. Fajas L, Miard S, Briggs M R., Auwerx J. Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase. J Lipid Res 2003 44 1652-1659
10. Yan H, Kermouni A, Abdel-Hafez M, Lau D C. Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. J Lipid Res 2003 44 424-429
11. Engelman J A., Berg A H., Lewis R Y., Lin A, Lisanti M P., Scherer P E. Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis. J Biol Chem 1999 274 35630-35638
12. Bouloumie A, Sengenes C, Portolan G, Galitzky J, Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 2001 50 2080-2086
13. Oberfield J L., Collins J L., Holmes C P., Goreham D M., Cooper J P., Cobb J E., Lenhard J M., Hull-Ryde E A., Mohr C P., Blanchard S G., Parks D J., Moore L B., Lehmann J M., Plunket K, Miller A B., Milburn M V., Kliewer S A., Willson T M. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. Proc Natl Acad Sci USA 1999 96 6102-6106
14. Hwang J T., Park I J., Shin J I., Lee Y K., Lee S K., Baik H W., Ha J, Park O J. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005 338 694-699
15. Vane J R., Botting R M. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 1998 47 (Suppl.2) S78-S87
16. Demeule M, Brossard M, Page M, Gingras D, Beliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta 2000 1478 51-60
17. Polya G. Biochemical targets of plant bioactive compounds: a pharmacological reference guide to sites of action and biological effects. Boca Raton, FL CRC Press 2003
18. Liu X, Kim J K., Li Y, Li J, Liu F, Chen X. Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. J Nutr 2005 135 165-171
19. Pinent M, Blade M C., Salvado M J., Arola L, Hackl H, Quackenbush J, Trajanoski Z, Ardévol A. Grape-seed derived procyanidins interfere with adipogenesis of 3T3-L1 cells at the onset of differentiation. Int J Obes (London) 2005 29 934-941
20. Spoor D C., Martineau L C., Leduc C, Benhaddou-Andaloussi A, Meddah B, Harris C, Burt A, Fraser M H., Coonishish J, Joly E, Cuerrier A, Bennett S A., Johns T, Prentki M, Arnason J T., Haddad P S. Selected plant species from the Cree pharmacopoeia of northern Quebec possess anti-diabetic potential. Can J Physiol Pharmacol 2006 84 847-858
21. Harbilas D, Martineau L C., Harris C S., Adeyiwola-Spoor D C., Saleem A, Lambert J, Caves D, Johns T, Prentki M, Cuerrier A, Arnason J T., Bennett S A., Haddad P S. Evaluation of the anti-diabetic potential of selected medicinal plant extracts from the Canadian Boreal Forest used to treat symptoms of diabetes: part II. Can J Physiol Pharmacol 2009 87 479-492
22. Leduc C, Coonishish J, Haddad P, Cuerrier A. Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: a novel approach in quantitative ethnobotany. J Ethnopharmacol 2006 105 55-63
23. Martineau L C., Muhammad A, Saleem A, Hervé J, Harris C S., Arnason J T., Haddad P S. Anti-adipogenic activities of Alnus incana and Populus balsamifera bark extracts, part II: bioassay-guided identification of actives salicortin and oregonin. Planta Med 2010
24. Benhaddou-Andaloussi A, Martineau L C., Vallerand D, Haddad Y, Afshar A, Settaf A, Haddad P S. Multiple molecular targets underlie the antidiabetic effect of Nigella sativa seed extract in skeletal muscle, adipocyte and liver cells. Diab Obes Metab 2010 12 148-157
25. Harris C S., Burt A J., Saleem A, Le P M., Martineau L C., Haddad P S., Bennett S A., Arnason J T. A single HPLC-PAD-APCI/MS method for the quantitative comparison of phenolic compounds found in leaf, stem, root and fruit extracts of Vaccinium angustifolium. Phytochem Anal 2007 18 161-169
26. Arnason J T., Hebda R J., Johns T. Use of plants for food and medicine by Native Peoples of Eastern Canada. Can J Bot 1981 59 2189-2325
27. Marles R J., Clavelle C, Monteleone L, Tays N, Burns D. Aboriginal plant use in Canada's northwest boreal forest. Vancouver UBC Press 2000
28. Yu K, Bayona W, Kallen C B., Harding H P., Ravera C P., McMahon G, Brown M, Lazar M A. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 1995 270 23975-23983